Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
Source:
Nasdaq GlobeNewswire
/
23 Feb 2024 06:00:26 America/Chicago
N/A
Share on,